\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesBack-to-back with the Commission's EU Missions Info Days, a virtual partnering event is organised on the new 2022 EU Missions calls of Horizon Europe. This event gives you the opportunity to get in touch with potential consortium partners for the forthcoming calls that have been published on 10 May 2022 in the amended EU Missions work programme 2021-2022. The event will include on-line bilateral meetings with partners interested in the same topics for 2022 calls.
More information and registration on the event website. The deadline to register is 17 May.
The event is organised by BRIDGE2HE, the Network of Horizon Europe National Contact Points.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Digital Europe Cybersecurity Defence
Research Infrastructures Culture and society Climate, Energy, Mobility
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
